Overview

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Dutasteride
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate